These 3 Dow Stocks Have New Stories Investors are Watching Now

Pfizer (NYSE:PFE): Current price $27.52

Shares of the Israeli pharmaceutical firm Protalix BioTherapeutics (AMEX:PLX) have taken off, following the website Calcalist reporting that the company is in discussions to be purchased for $1 billion. Pfizer has shown interest in acquiring Protalix, but at a valuation below the amount that Protalix prefers, says the website, which adds that Protalix’s board has chosen Citigroup (NYSE:C) to manage the selling process.

Your 1 Feature Stock Pick for February is hot off the press. Click here to discover it now!

pfe